COMP <GO>
SILO vs SBFM // REVENUE GROWTH (YOY)
Silo Pharma Inc. (NASDAQ) VS. Sunshine Biopharma Inc. (NASDAQ) • 15-METRIC TALLY: SILO 2
— SBFM 6
▲ REVENUE GROWTH (YOY) LEADER: SBFM
LAST: $1.25 (-6.72%) • MKT CAP: $2.4M
revenue-growth
0.00%
LAST: $3.33 (+7.07%) • MKT CAP: $2.5M
revenue-growth
4.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SILO VS. SBFM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SILO | SBFM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.60% | 33.80% | +4.80 | SILO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -21.40% | -13.60 | SBFM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -17.20% | -42.80 | SBFM | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -16.50% | -43.50 | SBFM | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 0.00% | 4.10% | -4.10 | SBFM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | SBFM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.1 | 27.3 | +6.81 | SILO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.4M | $2.5M | -$155.0K | SBFM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SILO REV | SBFM REV | SILO GROSS % | SBFM GROSS % | SILO FCF | SBFM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $72.1K | $36.3M | 38.6% | 33.8% | -$4.7M | -$5.5M |
| FY 2024 | $72.1K | $34.9M | 91.9% | 30.6% | -$3.8M | -$14.2M |
| FY 2023 | $72.1K | $24.1M | — | — | -$3.2M | -$8.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SILO // BETA —
SBFM // BETA —